An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online Oct. 18 in the International Journal of Urology.

UTIs may cause neurological symptoms, especially in older adults ... Some research suggests that older adults with urinary urgency or overactive bladder might experience changes in walking ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

Treatment with vibegron reduced the average number of micturition episodes per day and the average number of daily urgency episodes compared with placebo. The Food and Drug Administration (FDA ...